{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:14:48Z","timestamp":1789748088288,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI18C0284"],"award-info":[{"award-number":["HI18C0284"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003670","name":"National Evidence-based Healthcare Collaborating Agency","doi-asserted-by":"publisher","award":["NS21-004"],"award-info":[{"award-number":["NS21-004"]}],"id":[{"id":"10.13039\/501100003670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00198-025-07639-2","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T08:34:00Z","timestamp":1760517240000},"page":"2519-2530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Differential fracture risk in breast cancer patients based on endocrine therapy and age: a nationwide cohort study"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8092-2560","authenticated-orcid":false,"given":"Mi Kyung","family":"Kwak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1224-0875","authenticated-orcid":false,"given":"Seeyoun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7313-5227","authenticated-orcid":false,"given":"Jin-young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4515-1895","authenticated-orcid":false,"given":"Jung-Wee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3780-5668","authenticated-orcid":false,"given":"Ye Jhin","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6217-6798","authenticated-orcid":false,"given":"Bit-Na","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8763-5580","authenticated-orcid":false,"given":"Jean Kyung","family":"Bak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0651-2213","authenticated-orcid":false,"given":"Ha Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6564-4294","authenticated-orcid":false,"given":"Young-Kyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"issue":"3","key":"7639_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u201349","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"7639_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.4143\/crt.2022.128","volume":"54","author":"MJ Kang","year":"2022","unstructured":"Kang MJ, Won YJ, Lee JJ, Jung KW, Kim HJ, Kong HJ, Im JS, Seo HG (2022) Cancer statistics in korea: incidence, mortality, survival, and prevalence in 2019. Cancer Res Treatment: Off J Korean Cancer Assoc 54(2):330\u201344","journal-title":"Cancer Res Treatment: Off J Korean Cancer Assoc"},{"key":"7639_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11914-015-0277-9","volume":"13","author":"GA Clines","year":"2015","unstructured":"Clines GA, Choksi P, Van Poznak C (2015) Adjuvant endocrine therapy and bone health in breast cancer. Curr Osteoporos Rep 13:263\u2013273","journal-title":"Curr Osteoporos Rep"},{"key":"7639_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4048\/jbc.2023.26.e27","volume":"26","author":"JE Choi","year":"2023","unstructured":"Choi JE, Kim Z, Park CS et al (2023) Breast cancer statistics in Korea, 2019. J Breast Cancer 26:207\u2013220","journal-title":"J Breast Cancer"},{"key":"7639_CR5","doi-asserted-by":"publisher","first-page":"484","DOI":"10.6004\/jnccn.2021.0023","volume":"19","author":"WJ Gradishar","year":"2021","unstructured":"Gradishar WJ, Moran MS, Abraham J et al (2021) NCCN guidelines\u00ae insights: breast cancer, version 4.2021. J Natl Compr Canc Netw 19:484\u2013493","journal-title":"J Natl Compr Canc Netw"},{"key":"7639_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/bjc.1971.33","volume":"25","author":"MP Cole","year":"1971","unstructured":"Cole MP, Jones C, Todd I (1971) A new anti-oestrogenic agent in late breast cancer: an early clinical appraisal of ICI46474. Br J Cancer 25:270","journal-title":"Br J Cancer"},{"key":"7639_CR7","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1210\/endo-92-3-866","volume":"92","author":"WC Schwarzel","year":"1973","unstructured":"Schwarzel WC, Kruggel WG, Brodie HJ (1973) Studies on the mechanism of estrogen biosynthesis. VIII. The development of inhibitors of the enzyme system in human placenta. Endocrinology 92:866\u2013880","journal-title":"Endocrinology"},{"key":"7639_CR8","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1056\/NEJM199203263261302","volume":"326","author":"RR Love","year":"1992","unstructured":"Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC, Carbone PP, DeMets DL (1992) Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 326:852\u2013856","journal-title":"N Engl J Med"},{"key":"7639_CR9","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S2213-8587(18)30047-0","volume":"6","author":"TD Rachner","year":"2018","unstructured":"Rachner TD, Coleman R, Hadji P, Hofbauer LC (2018) Bone health during endocrine therapy for cancer. Lancet Diabetes Endocrinol 6:901\u2013910","journal-title":"Lancet Diabetes Endocrinol"},{"key":"7639_CR10","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1200\/JCO.2007.11.0726","volume":"26","author":"R Eastell","year":"2008","unstructured":"Eastell R, Adams JE, Coleman RE, Howell A, Hannon RA, Cuzick J, Mackey JR, Beckmann MW, Clack G (2008) Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial. J Clin Oncol 26:1051\u20131057","journal-title":"J Clin Oncol"},{"key":"7639_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1200\/JCO.1996.14.1.78","volume":"14","author":"TJ Powles","year":"1996","unstructured":"Powles TJ, Hickish T, Kanis JA, Tidy A, Ashley S (1996) Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol 14:78\u201384","journal-title":"J Clin Oncol"},{"key":"7639_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","volume":"365","author":"A Howell","year":"2005","unstructured":"Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, Hoctin-Boes G, Houghton J, Locker GY, Tobias JS (2005) Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years\u2019 adjuvant treatment for breast cancer. Lancet 365:60\u201362","journal-title":"Lancet"},{"key":"7639_CR13","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/annonc\/mdp033","volume":"20","author":"M Rabaglio","year":"2009","unstructured":"Rabaglio M, Sun Z, Price KN et al (2009) Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1\u201398 trial. Ann Oncol 20:1489\u20131498","journal-title":"Ann Oncol"},{"key":"7639_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1470-2045(07)70003-7","volume":"8","author":"RE Coleman","year":"2007","unstructured":"Coleman RE, Banks LM, Girgis SI et al (2007) Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study. Lancet Oncol 8:119\u2013127","journal-title":"Lancet Oncol"},{"key":"7639_CR15","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/annonc\/mdn762","volume":"20","author":"P Hadji","year":"2009","unstructured":"Hadji P, Ziller M, Kieback DG, Dornoff W, Tessen HW, Menschik T, Kuck J, Melchert F, Hasenburg A (2009) Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy. Ann Oncol 20:1203\u20131209","journal-title":"Ann Oncol"},{"key":"7639_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.breast.2014.12.008","volume":"24","author":"C Koopal","year":"2015","unstructured":"Koopal C, Janssen-Heijnen ML, van de Wouw AJ, van den Bergh JP (2015) Fracture incidence in pre- and postmenopausal women after completion of adjuvant hormonal therapy for breast cancer. Breast 24:153\u2013158","journal-title":"Breast"},{"key":"7639_CR17","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1056\/NEJMoa0806285","volume":"360","author":"M Gnant","year":"2009","unstructured":"Gnant M, Mlineritsch B, Schippinger W et al (2009) Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N Engl J Med 360:679\u2013691","journal-title":"N Engl J Med"},{"key":"7639_CR18","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1200\/JCO.2006.08.8054","volume":"25","author":"M Kaufmann","year":"2007","unstructured":"Kaufmann M, Jonat W, Hilfrich J, Eidtmann H, Gademann G, Zuna I, von Minckwitz G (2007) Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 study. J Clin Oncol 25:2664\u20132670","journal-title":"J Clin Oncol"},{"key":"7639_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2019.100254","volume":"18","author":"U Stumpf","year":"2019","unstructured":"Stumpf U, Kostev K, Kyvernitakis J, B\u00f6cker W, Hadji P (2019) Incidence of fractures in young women with breast cancer - a retrospective cohort study. J Bone Oncol 18:100254","journal-title":"J Bone Oncol"},{"key":"7639_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4143\/crt.2005.37.6.325","volume":"37","author":"HR Shin","year":"2005","unstructured":"Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, Noh HI, Lee JK, Pisani P, Park JG (2005) Nationwide cancer incidence in Korea, 1999\u20132001; first result using the national cancer incidence database. Cancer Res Treat 37:325\u2013331","journal-title":"Cancer Res Treat"},{"key":"7639_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10091724","author":"YK Lee","year":"2022","unstructured":"Lee YK, Yoo JI, Kim TY, Ha YC, Koo KH, Choi H, Lee SM, Suh DC (2022) Validation of operational definition to identify patients with osteoporotic hip fractures in administrative claims data. Healthcare. https:\/\/doi.org\/10.3390\/healthcare10091724","journal-title":"Healthcare"},{"key":"7639_CR22","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e249","volume":"37","author":"MH Yu","year":"2022","unstructured":"Yu MH, Hong N, Lee S et al (2022) Operational definition identifying osteoporotic vertebral fractures in the claims database. J Korean Med Sci 37:e249","journal-title":"J Korean Med Sci"},{"key":"7639_CR23","doi-asserted-by":"publisher","first-page":"1026.e1021","DOI":"10.1016\/j.jhsa.2021.03.001","volume":"46","author":"YK Lee","year":"2021","unstructured":"Lee YK, Park C, Won S, Park JW, Koo KH, Ha YC, Jung HS (2021) Validation of an operational definition to identify distal radius fractures in a national health insurance database. J Hand Surg Am 46:1026.e1021-1026.e1027","journal-title":"J Hand Surg Am"},{"key":"7639_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","volume":"326","author":"DG Altman","year":"2003","unstructured":"Altman DG, Bland JM (2003) Interaction revisited: the difference between two estimates. BMJ 326:219","journal-title":"BMJ"},{"key":"7639_CR25","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/sj.bjc.6690188","volume":"79","author":"JA Kanis","year":"1999","unstructured":"Kanis JA, McCloskey EV, Powles T, Paterson AH, Ashley S, Spector T (1999) A high incidence of vertebral fracture in women with breast cancer. Br J Cancer 79:1179\u20131181","journal-title":"Br J Cancer"},{"key":"7639_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.11005\/jbm.2020.27.4.281","volume":"27","author":"SH Ahn","year":"2020","unstructured":"Ahn SH, Park SM, Park SY et al (2020) Osteoporosis and osteoporotic fracture fact sheet in Korea. J Bone Metab 27:281\u2013290","journal-title":"J Bone Metab"},{"key":"7639_CR27","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1200\/JCO.2005.02.3515","volume":"24","author":"L Vehmanen","year":"2006","unstructured":"Vehmanen L, Elomaa I, Blomqvist C, Saarto T (2006) Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status. J Clin Oncol 24:675\u2013680","journal-title":"J Clin Oncol"},{"key":"7639_CR28","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1200\/JCO.2004.08.148","volume":"22","author":"A Sverrisdottir","year":"2004","unstructured":"Sverrisdottir A, Fornander T, Jacobsson H, von Schoultz E, Rutqvist LE (2004) Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy. J Clin Oncol 22:3694\u20133699","journal-title":"J Clin Oncol"},{"key":"7639_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0169-6009(89)90081-0","volume":"7","author":"S Feldmann","year":"1989","unstructured":"Feldmann S, Minne HW, Parvizi S, Pfeifer M, Lempert UG, Bauss F, Ziegler R (1989) Antiestrogen and antiandrogen administration reduce bone mass in the rat. Bone Miner 7:245\u2013254","journal-title":"Bone Miner"},{"key":"7639_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/BF01807038","volume":"41","author":"JD Sibonga","year":"1996","unstructured":"Sibonga JD, Evans GL, Hauck ER, Bell NH, Turner RT (1996) Ovarian status influences the skeletal effects of tamoxifen in adult rats. Breast Cancer Res Treat 41:71\u201379","journal-title":"Breast Cancer Res Treat"},{"key":"7639_CR31","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1007\/s00198-018-4642-2","volume":"29","author":"I Kyvernitakis","year":"2018","unstructured":"Kyvernitakis I, Kostev K, Hadji P (2018) The tamoxifen paradox-influence of adjuvant tamoxifen on fracture risk in pre- and postmenopausal women with breast cancer. Osteoporos Int 29:2557\u20132564","journal-title":"Osteoporos Int"},{"key":"7639_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00366","volume":"10","author":"J Lee","year":"2020","unstructured":"Lee J, Alqudaihi HM, Kang MS et al (2020) Effect of tamoxifen on the risk of osteoporosis and osteoporotic fracture in younger breast cancer survivors: a nationwide study. Front Oncol 10:366","journal-title":"Front Oncol"},{"key":"7639_CR33","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.1200\/JCO.2007.15.7123","volume":"26","author":"AL Cooke","year":"2008","unstructured":"Cooke AL, Metge C, Lix L, Prior HJ, Leslie WD (2008) Tamoxifen use and osteoporotic fracture risk: a population-based analysis. J Clin Oncol 26:5227\u20135232","journal-title":"J Clin Oncol"},{"key":"7639_CR34","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/S1470-2045(08)70204-3","volume":"9","author":"M Gnant","year":"2008","unstructured":"Gnant M, Mlineritsch B, Luschin-Ebengreuth G et al (2008) Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy. Lancet Oncol 9:840\u2013849","journal-title":"Lancet Oncol"},{"key":"7639_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/1759720X18759291","volume":"10","author":"OL Tseng","year":"2018","unstructured":"Tseng OL, Spinelli JJ, Gotay CC, Ho WY, McBride ML, Dawes MG (2018) Aromatase inhibitors are associated with a higher fracture risk than tamoxifen: a systematic review and meta-analysis. Ther Adv Musculoskelet Dis 10:71\u201390","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"7639_CR36","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1634\/theoncologist.2019-0149","volume":"24","author":"WD Leslie","year":"2019","unstructured":"Leslie WD, Morin SN, Lix LM, Niraula S, McCloskey EV, Johansson H, Harvey NC, Kanis JA (2019) Fracture risk in women with breast cancer initiating aromatase inhibitor therapy: a registry-based cohort study. Oncologist 24:1432\u20131438","journal-title":"Oncologist"},{"key":"7639_CR37","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s11764-017-0666-4","volume":"12","author":"JM Neuner","year":"2018","unstructured":"Neuner JM, Shi Y, Kong AL, Kamaraju S, Smith EC, Smallwood AJ, Laud PW, Charlson JA (2018) Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy. J Cancer Surviv 12:268\u2013275","journal-title":"J Cancer Surviv"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07639-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-025-07639-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07639-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T13:31:08Z","timestamp":1764682268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-025-07639-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["7639"],"URL":"https:\/\/doi.org\/10.1007\/s00198-025-07639-2","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of Human and Animal Rights"}},{"value":"This study was exempted from obtaining patient consent by the Institutional Review Board\/Ethics Committee of Seoul National University, Bundang Hospital of Korea (IRB No. X-1801\u2013447-908) because it did not involve human subjects, and all data provided by the KCCR and KNHIS were anonymized.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Mi Kyung Kwak, Seeyoun Lee, Jin-young Lee, Jung-Wee Park, Ye Jhin Jeon, Bit-Na Yoo, Jean Kyung Bak, Ha Young Kim, and Young-Kyun Lee declare that they have no conflict of interest. The funders had no role in the study\u2019s design; in the collection, analysis, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}